🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of your participation in this study is to help answer t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p
Start Date
2007-01
Trial ID
NCT00424593
Treatments Being Tested
The primary purpose of this study is to evaluate if the effectiveness of de...
Status
Completed
Location
Beijing Anding Hospital
Start Date
2020-06-18
Trial ID
NCT04364997
Treatments Being Tested
A Randomized Phase II study Comparing Lorcaserin versus Duloxetine for the ...
Status
Unknown
Location
Cancer Treatment Centers of America - Atlanta
Start Date
2019-06
Trial ID
NCT03812523
Treatments Being Tested
The purpose of the study is to assess the long term safety of duloxetine in...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-09
Trial ID
NCT01914666
Treatments Being Tested
This study is designed to primarily assess the efficacy and safety of dulox...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2008-10
Trial ID
NCT00755807
Treatments Being Tested
This phase II/III trial studies the best dose of duloxetine and how well it...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-06-17
Trial ID
NCT04137107
The purpose of this study is to assess whether duloxetine is superior to pl...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2009-03
Trial ID
NCT00849693
Treatments Being Tested
The purpose of this research is is to determine if the combination of non-o...
Status
Completed
Location
Wake Forest Baptist Health Department of Rheumatology
Start Date
2021-02-24
Trial ID
NCT04395001
Acute, double-blind, adaptively randomized treatment with duloxetine or esc...
Status
Recruiting
Location
University of Cincinnati
Start Date
2020-01-01
Trial ID
NCT04245436
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy of the study dru...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2014-10
Trial ID
NCT02248480
Treatments Being Tested